Gopal R M, Pomroy W E, West D M
Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand.
Int J Parasitol. 1999 May;29(5):781-6. doi: 10.1016/s0020-7519(99)00032-6.
Twelve Romney lambs and 10 Angora goats were infected with 7000 infective third-stage larvae (89% Trichostrongylus, 11% Ostertagia) collected from goats suspected of harbouring ivermectin-resistant nematodes. On 28 days p.i., the lambs and goats were divided into treatment and control groups of six and five animals, respectively. The animals in the treatment groups were treated with ivermectin (0.2 mg/kg) and necropsied 35 days p.i. Faecal egg counts were estimated on days 28 and 35 p.i. and larval development assays (LDAs) were conducted on 22, 24, 26, 28, 30, 32, 34 and 35 days p.i. The ivermectin treatment reduced Trichostronglus colubriformis burdens by 39% and 13% and Ostertagia circumcincta by 33% and 0% in lambs and goats, respectively. When compared with a susceptible strain, the LDAs indicated a resistance factor before treatment in lambs for T. colubriformis of 2.6 and 1.5 with ivermectin and avermectin B2, respectively, which rose to 3.4 and 2.0 after treatment. The LD50 values of the two control groups were relatively constant throughout the experiment. Prior to ivermectin treatment the LD50 values of the treated groups were similar (P > 0.05) to the control groups but following ivermectin treatment their LD50 values increased steadily until the animals were killed on 35 days p.i. The LD50 values for ivermectin and avermectin B2 of sheep were always slightly higher and significantly different (P < 0.01) than those of goats indicating a host effect on this parameter. The greater reduction in worm counts in goats suggests a difference in the efficacy of ivermectin between lambs and goats. This is the first confirmed report of ivermectin resistance in a field strain of T. colubriformis.
12只罗姆尼羔羊和10只安哥拉山羊被感染了7000条感染性三期幼虫(89%为毛圆线虫,11%为奥斯特他线虫),这些幼虫采自疑似携带伊维菌素抗性线虫的山羊。感染后28天,羔羊和山羊分别被分为治疗组和对照组,每组分别有6只和5只动物。治疗组动物用伊维菌素(0.2毫克/千克)进行治疗,并在感染后35天进行剖检。在感染后28天和35天估计粪便虫卵计数,并在感染后22、24、26、28、30、32、34和35天进行幼虫发育试验(LDA)。伊维菌素治疗使羔羊和山羊体内的蛇形毛圆线虫数量分别减少了39%和13%,使环纹奥斯特他线虫数量分别减少了33%和0%。与敏感品系相比,LDA表明,在治疗前,羔羊体内蛇形毛圆线虫对伊维菌素和阿维菌素B2的抗性因子分别为2.6和1.5,治疗后分别升至3.4和2.0。两个对照组的半数致死剂量(LD50)值在整个实验过程中相对稳定。在伊维菌素治疗前,治疗组的LD50值与对照组相似(P>0.05),但在伊维菌素治疗后,其LD50值稳步上升,直到在感染后35天处死动物。绵羊对伊维菌素和阿维菌素B2的LD50值总是略高于山羊,且差异显著(P<0.01),表明宿主对该参数有影响。山羊体内蠕虫数量减少幅度更大,表明伊维菌素在羔羊和山羊中的疗效存在差异。这是首次证实蛇形毛圆线虫野外品系对伊维菌素有抗性的报告。